Tupling AR, Vigna C, Ford RJ, Tsuchiya SC, Graham DA, Denniss SG, Rush JW. Effects of buthionine sulfoximine treatment on diaphragm contractility and SR Ca 2ϩ pump function in rats. J Appl Physiol 103: 1921-1928, 2007. First published August 23, 2007; doi:10.1152/japplphysiol.00529.2007.-The purpose of this study was to examine the effects of glutathione (GSH) depletion and cellular oxidation on rat diaphragm contractility and sarco(endo)plasmic reticulum Ca 2ϩ -ATPase (SERCA) function in vitro under basal conditions and following fatiguing stimulation. Buthionine sulfoximine (BSO) treatment (n ϭ 10) for 10 days (20 mM in drinking water) reduced (P Ͻ 0.05) diaphragm GSH content (nmol/mg protein) and the ratio of GSH to glutathione disulfide (GSH/GSSG) by 91% and 71%, respectively, compared with controls (CTL) (n ϭ 10). Western blotting showed that Hsp70 expression in diaphragm was not increased (P Ͼ 0.05) with BSO treatment. As hypothesized, basal peak twitch force (g/mm 2 ) was increased (P Ͻ 0.05), and fatigability in response to repetitive stimulation (350-ms trains at 100 Hz once every 1 s for 5 min) was also increased (P Ͻ 0.05) in BSO compared with CTL. Both Ca 2ϩ uptake and maximal SERCA activity (mol ⅐ g protein Ϫ1 ⅐ min Ϫ1 ) measured in diaphragm homogenates that were prepared at rest were increased (P Ͻ 0.05) with BSO treatment, an effect that could be partly explained by a twofold increase (P Ͻ 0.05) in SERCA2a expression with BSO. In response to the 5-min stimulation protocol, both Ca 2ϩ uptake and maximal SERCA activity were increased (P Ͻ 0.05) in CTL but not (P Ͼ 0.05) in BSO diaphragm. We conclude that 1) cellular redox state is more optimal for contractile function and fatigability is increased in rat diaphragm following BSO treatment, 2) SERCA2a expression is modulated by redox signaling, and 3) regulation of SERCA function in working diaphragm is altered following BSO treatment. glutathione; oxidative stress; calcium-adenosinetriphosphatase IN RESTING SKELETAL MUSCLE, reactive oxygen species (ROS) and reactive nitrogen species (RNS) exist at low but measurable concentrations and determine the basal intracellular thiol/disulfide redox state (6, 15, 34) . Redox homeostasis in skeletal muscle is maintained by the balance of both ROS and RNS production and buffering by a variety of both enzymatic and nonenzymatic antioxidant systems (6, 15, 33) . Imbalances between prooxidant and antioxidant activity, resulting in accumulation of ROS and/or RNS, due either to an increased production of ROS and RNS or deficiency in antioxidant defense, would shift cellular redox to a more oxidized state and reduce the thiol/disulfide ratio. Moderate increases in ROS and/or RNS act as important regulatory signals for various physiological processes, whereas excessive accumulation of ROS and/or RNS causes oxidative stress and damage resulting in loss of muscle function (6, 24, 33, 34) .
Redox regulation of skeletal muscle contractility has been examined extensively, and a model developed by Reid et al. (32) depicts the biphasic effects of cellular redox state on isometric force (for review, see Ref. 33) . Modest ROS supplementation shifts intracellular redox from the basal state toward a slightly more oxidized state that is more optimal for force production, causing isometric force to increase (3, 28, 32) . On the other hand, excessive ROS production that occurs with strenuous exercise (5, 31, 44, 49) , or exposure to high concentrations of ROS causes oxidative stress and inhibits force production (i.e., causes muscle fatigue) (33) .
Glutathione is an important nonenzymatic cellular antioxidant that functions as an electron donor for the glutathione peroxidase (GPX) reaction and has direct antioxidant properties (16, 41) . GPX catalyzes the conversion of reduced glutathione (GSH) to its oxidized state (GSSG) in the presence of increased peroxides (i.e., H 2 O 2 ); subsequently GSSG can be recycled back to GSH in the glutathione reductase (GR) reaction (41) . Administration of the glutamate-cysteine ligase inhibitor buthionine sulfoximine (BSO) has been shown to deplete cellular glutathione (i.e., reduce antioxidant defense) and to reduce the GSH/GSSG ratio (i.e., shift basal redox to a more oxidized state) in rat diaphragm (26) and hindlimb skeletal muscle (39) . As would be predicted by the model proposed by Reid et al. (32) , BSO treatment (20 mM BSO in drinking water for 7 days) resulted in increased basal peak twitch force and exacerbated fatigue in rat diaphragm muscle subjected to inspiratory resistive loading (26) . Therefore, BSO treatment appears to be a useful research model for investigating redox regulation of various physiological processes in skeletal muscle under basal conditions and in response to fatiguing muscle contractile activity.
Sarco(endo)plasmic reticulum Ca 2ϩ -ATPases (SERCAs) are 110-kDa integral membrane proteins that catalyze the ATP-dependent transport of Ca 2ϩ from the cytosol to the lumen of the sarco(endo)plasmic reticulum (SR) (21) . The two main SERCA isoforms that are expressed in skeletal muscle, namely SERCA1a and SERCA2a, contain 24 and 26 Cys residues, respectively, and therefore are highly susceptible to oxidative damage and loss of function when exposed to oxidative stress (40, 50) . For example, SERCA activity is depressed following prolonged skeletal muscle ischemia (48) , myocardial ischemia-reperfusion (27) , fatiguing exercise (45) , aging (42) , and heat stress (4, 19, 37, 46) . However, to what extent SERCA function is modulated by redox signaling in skeletal muscle under basal conditions is not well known.
In this study, we treated rats with BSO for 10 days to examine the effects of GSH depletion and changes in basal redox state on diaphragm contractility and SERCA function measured in vitro under resting conditions and following fatiguing stimulation. It was hypothesized that BSO treatment would result in increased basal isometric force and increased fatigability of diaphragm muscle strips assessed in vitro. Second, we hypothesized that SERCA function measured in homogenates would not be altered under basal conditions but would be reduced to a greater extent in response to fatiguing stimulation following BSO treatment.
MATERIALS AND METHODS
Animal description and care. The animals used for this study were also used for another study examining the effects of GSH depletion in vivo on isolated blood vessel function. These results along with details of the animal model have been published elsewhere (10) . In brief, a total of 20 adult male Sprague-Dawley rats were used for this study. The animals were housed two to three per cage in a climatecontrolled facility on reverse 12-h light cycle. All rats were maintained on a normal diet of 22/5 rodent diet lab chow (Harlan), with the control (CTL) rats receiving normal tap water and the BSO rats receiving water containing 20 mM L-buthionine-(S,R)-sulfoximine (BSO) for 10 consecutive days. All experiments and protocols were approved by the University of Waterloo Animal Care Committee and were in accordance with the guidelines of the Canadian Council on Animal Care.
Glutathione detection. To determine the effects of BSO treatment on diaphragm glutathione content, tissue homogenates were prepared from costal diaphragm samples from both CTL and BSO-treated animals, and glutathione was assayed by HPLC according to Reed et al. (30) . Homogenates were prepared with a 1:10 dilution in homogenizing media (2 mM phenanthroline in 7% perchloric acid) using handheld glass homogenizers. Homogenates were centrifuged at 4°C and 1,000 rpm for 10 min; 250-l aliquots of supernatant were removed and treated with 10 l of 0.4 M iodoacetic acid and then neutralized by excess NaHCO 3. After incubation in the dark at room temperature for 1 h, 2 l of alcoholic 1-fluoro-2, 4-dinitrobenzene (1.5 ml/98.5 ml absolute ethanol) was added to each sample and allowed to react in the dark for 8 h. Samples (25 l injections) were run on a Waters Alliance 2695 system using Varian (Rainin) Mircosorb 5-M amino 25 cm ϫ 4.5 cm columns at room temperature for 35 min with a flow rate of 1 ml/min and detection at 350 nm.
Electrical stimulation and basal muscle contractile measurements. Basal isometric force of diaphragm muscles were measured in vitro from CTL and BSO-treated rats. Experiments were conducted on two CTL and two BSO-treated rats each day. Following the 10-day drug administration period, animals were anesthetized (pentobarbital sodium, 0.65 mg/kg ip), and each diaphragm muscle was exposed, removed with intact ribs and tendons, and placed into oxygenated Krebs solution (95% O 2-5% CO2) containing (in mM) 118 NaCl, 25 NaHCO3, 11 glucose, 1.2 KHPO4, 1.9 CaCl2, and 1.2 MgSO4, pH 7.4, and maintained at room temperature. Each diaphragm was trimmed and cut into a single strip from the costal region spanning from the central tendon at one end to the ribcage at the other end. Each diaphragm muscle strip was mounted vertically in a jacketed muscle bath (Radnotti Glass, Monrovia, CA) containing oxygenated Krebs solution (33°C) between a Plexiglas clamp and a servomotor (Cambridge Technologies, model 300H Dual Mode Servo) used to measure force output.
Stimulation was applied by a Grass S88 stimulator (Grass Instruments, Quincy, MA) via closely flanking platinum wire electrodes. A supramaximal stimulation voltage was used (measured characteristics 175 mA at 54 V) with a pulse duration of 0.2 ms. Force data were collected on-line using a 640-A signal interface (Aurora Scientific) connected to a National Instruments 16-bit analog-to-digital card and analyzed using the Dynamic Muscle Control and Data Acquisition (DMC) and Dynamic Muscle Analysis (DMA) Software (Aurora Scientific). Muscle length (L o) was adjusted to obtain maximal isometric twitch force (g).
Fatigue protocol. To investigate the hypotheses that diaphragm fatigability would be greater and that SERCA function would be impaired to a greater extent in response to intense contractile activity following BSO treatment compared with CTL, a 5-min high-frequency stimulation protocol consisting of 350-ms contractions at 100 Hz, once per second, was employed. Fatigue was assessed by determining the number of contractions needed to induce a 50% loss in maximum force (50% rundown) and by the overall force loss after 5 min expressed as a percentage of initial force. After the contractile and fatigue properties were measured, the diaphragm muscle strips were trimmed of the remnants of the central tendon and the rib, blotted on filter paper, and weighed on an analytical balance. The total muscle fiber cross-sectional area of the muscles was determined by dividing the muscle mass (mg) by the product of Lo (mm) and 1.06 mg/mm 3 , the density of mammalian skeletal muscle (25) . Force data were normalized for total muscle fiber cross-sectional area.
Sample preparation for assessment of SERCA function in vitro. To investigate the effects of BSO treatment and fatiguing contractile activity on SERCA function, Ca 2ϩ -ATPase activity and Ca 2ϩ uptake were measured in diaphragm homogenates. Basal (i.e., resting) SERCA function was determined in homogenates that were prepared from costal diaphragm samples taken immediately following removal of the whole diaphragm from both CTL and BSO-treated animals. The effects of fatiguing contractile activity on SERCA function were determined in homogenates that were prepared from diaphragm muscle strips immediately following the fatigue protocol. Homogenates were prepared with 30 -40 mg of tissue diluted 11:1 (vol/wt) in an ice-cold buffer containing (in mM) 250 sucrose, 5 HEPES, 10 NaN3, and 0.2 PMSF (pH 7.5) by using a handheld glass homogenizer (Duall 20, Kontes). The homogenates were separated into multiple aliquots and frozen immediately in liquid nitrogen for later analysis. On a given analytical day, aliquots were thawed and processed for the duplicate measurements of Ca 2ϩ -ATPase activity and Ca 2ϩ uptake. Total protein concentration of the homogenates was measured by the method of Lowry, as modified by Schacterle and Pollock (35) . Ca 2ϩ -dependent Ca 2ϩ -ATPase activity. Measurements of Ca 2ϩ -induced Ca 2ϩ -ATPase activity were made at 37°C using a spectrophotometric assay as described previously (47) . Briefly, the assay buffer contained (in mM) 20 HEPES, 200 KCl, 15 MgCl2, 1 EGTA, 10 NaN 3, 5 ATP, and 10 phosphoenolpyruvate, pH 7.0. Immediately before initiating the reaction with Ca 2ϩ additions, 18 U/ml lactate dehydrogenase enzyme, 18 U/ml pyruvate kinase enzyme, 0.3 mM NADH, 1 M Ca 2ϩ ionophore A23187 (Sigma, C-7522), and the tissue (50 g of total protein) were added to 1 ml of assay buffer. Ca 2ϩ -dependent Ca 2ϩ -ATPase activity was assessed by adding 4 -11 l of 100 mM CaCl 2 in 0.5-l additions until Vmax was reached. The free Ca 2ϩ concentration ([Ca 2ϩ ]f) corresponding to each CaCl2 addition was assessed separately, on a different SR aliquot, by use of dual-wavelength spectrofluorometry and the Ca 2ϩ -fluorescent dye indo-1. Basal activity was measured in the presence of 40 M cyclopiazonic acid, which is a specific SERCA inhibitor. The difference between total and basal activities represents the Ca 2ϩ -activated SR Ca 2ϩ -ATPase activity. The data were analyzed by nonlinear regression with computer software (GraphPad Software) and the K Ca (defined as the negative logarithm of the Ca 2ϩ concentration required to attain 50% of maximal Ca 2ϩ -ATPase activity) and Hill coefficient (nH) values were calculated using an equation for a general cooperative model for substrate activation. The values for maximal Ca 2ϩ -ATPase activity that occurred at pCa 5.6 to pCa 5.2 were taken directly from the experimental data and normalized for total protein concentration.
SR Ca
2ϩ uptake. Oxalate-supported Ca 2ϩ uptake was measured using the Ca 2ϩ fluorescent dye indo-1 as described previously (47) . Fluorescence measurements were collected on a dual-emission wavelength spectrofluorometer (Ratiomaster System, Photon Technology International). The excitation wavelength was set to 355 nm, and 405 and 485 nm correspond to the emission wavelength for bound (F) and free (G) indo-1, respectively. Photon counts were simultaneously collected for each wavelength. Before each analytical session, the background fluorescence was determined in the absence of indo-1 and subtracted before starting each assay. The reaction buffer contained 200 mM KCl, 20 mM HEPES, 10 mM NaN 3, 0.005 M N,N,NЈ,NЈ-tetrakis(2-pyridylmethyl)ethylenediamine (TPEN), 5 mM oxalate, and 15 mM MgCl 2, pH 7.0. Before initiating data collection, the assay buffer was heated to 37°C, and 1.5 M indo-1, 2.0 l of 10 mM CaCl 2, and 50 l of diaphragm homogenate were added to a cuvette containing 2.0 ml of buffer. Once these additions were made, data collection was started. After a brief period, 40 
where Kd represents the equilibrium constant for the interaction between Ca 2ϩ and indo-1. A Kd value of 250 nM was used (12) . Rmin is the minimum value of R at addition of 250 M EGTA, Gmax is the maximum value of G at addition of 250 M EGTA, Gmin is the minimum value of G at addition of 1 mM CaCl2, and Rmax is the maximum value of R at addition of 1 mM CaCl2. For all Ca 2ϩ uptake trials, Rmin and Rmax were not determined until Ca 2ϩ uptake had plateaued, which occurred at ϳ75 nM [Ca 2ϩ ]f. The generated curve from Eq. 1, [Ca 2ϩ ]f vs. time, was smoothed over 21 points using the Savitsky-Golay algorithm. Linear regression was performed on values of [Ca 2ϩ ]f between 1.4 and 1.6 M (i.e., pCa 5.82). Differentiating the linear fit curve allowed the determination of Ca 2ϩ -uptake rates, which were normalized for total protein concentration.
Western blot analysis. Western blotting was performed to determine the relative expression levels of Hsp70, SERCA1a, and SERCA2a in diaphragm muscle from CTL and BSO-treated rats. After ensuring linearity of band density, 20 l of the homogenate (Hsp70, 5 g total protein; SERCA1a, 1 g total protein; SERCA2a, 20 g total protein) were applied to 10% (Hsp70) or 7% (SERCA1a and SERCA2a) polyacrylamide gels, and proteins were separated using standard SDS-PAGE protocols (17) and then transferred to polyvinlyidene difluoride (PVDF) membranes (Roche Diagnostics, Mannheim, Germany). A biotinylated ladder was used as a molecular weight standard (Cell Signaling Technology, Beverly, MA). The membranes were cut horizontally to separate proteins of molecular weight above and below ϳ60 kDa to separate the Hsp70 (ϳ70 kDa) and SERCA protein bands (ϳ100 kDa) from the ␣-actin protein band (ϳ42 kDa) before applying the primary antibodies. After blocking with a 10% skim milk suspension, the membranes containing the higher molecular weight proteins (i.e., above ϳ60 kDa) were incubated for either 16 h with anti-Hsp70 monoclonal antibody SPA-810 (Stressgen Biotechnologies) or 1 h with either anti-SERCA1a monoclonal antibody A52 (54) or anti-SERCA2a antibody 2A7-A1 (Affinity Bioreagents), and the membranes containing the lower molecular weight proteins (i.e., below ϳ60 kDa) were incubated for 1 h with anti-␣-sarcomeric actin antibody 5C5 (Sigma) to control for protein loading. Then, after washing in Tris ⅐ HCl, pH 7.5, 150 mM NaCl, 0.1% Tween 20 (Tris-buffered saline-0.1% Tween), the membranes were treated with horseradish peroxidase-conjugated anti-mouse secondary antibody (Santa Cruz Biotechnology). Membranes were washed in Tris-buffered saline-0.1% Tween, and the signals were detected with an enhanced chemiluminescence kit (Amersham Pharmacia Biotech) using a bioimaging system, and densitometric analysis was performed using the GeneSnap software (Syngene). All samples were run in duplicate on separate gels, and the Hsp70, SERCA1a and SERCA2a expression levels were expressed relative to ␣-actin content and normalized to the CTL rest sample.
Statistical analysis. To determine the effects of BSO treatment (CTL vs. BSO) and fatiguing stimulation (rest vs. fatigue) for both Ca 2ϩ -ATPase activity and Ca 2ϩ -uptake measures, a two-way ANOVA was employed. For all other measures, statistical analysis was performed by Student's paired t-test between CTL and BSOtreated diaphragm. The significance level was set at 0.05 (P Ͻ 0.05), and when appropriate a Newman-Keuls post hoc test was used to compare specific means. All data are presented as means Ϯ SE.
RESULTS

Diaphragm glutathione content.
The effects of BSO treatment on diaphragm GSH, GSSG, and the ratio GSH/GSSG are illustrated in Fig. 1 . Compared with CTL animals, diaphragm GSH levels were reduced (P Ͻ 0.05) by ϳ91% (Fig. 1A) , and GSSG levels were reduced by ϳ62% (Fig. 1B ) in animals treated with BSO, which indicates that cellular antioxidant buffering capacity was reduced in BSO-treated diaphragm. The calculated ratio GSH/GSSG was also reduced by ϳ71% with BSO treatment (Fig. 1C) , indicating a shift toward a more oxidized cellular redox state in diaphragm muscle from BSOtreated animals compared with CTL.
Diaphragm Hsp70 Content. It was of interest to further characterize the effects of BSO treatment on cellular redox state to determine whether the shift toward a more oxidized environment that occurred in BSO-treated diaphragm was sufficient to induce a cellular stress response. Western blot analysis was carried out on homogenates prepared from diaphragm muscles from CTL and BSO-treated animals to determine the relative expression levels of Hsp70, which is the most highly induced protein of the cellular stress response and is rapidly upregulated under conditions of oxidative stress (51). Overall, there were no differences (P Ͼ 0.05) in Hsp70 expression levels between CTL and BSO-treated diaphragm muscles (Fig. 2) .
In vitro basal isometric force in rat diaphragm. For diaphragm muscle strips in vitro, "basal state" is defined as the unfatigued muscle (33) . The effects of BSO treatment on in vitro basal peak twitch force and peak tetanic force (100 Hz) are shown in Fig. 3 . Note that the first contraction during the fatigue protocol was taken to represent basal peak tetanic force. Basal peak twitch force was ϳ31% higher (P Ͻ 0.05) in diaphragm strips from BSO-treated animals compared with CTL (Fig. 3A) . Basal peak tetanic force was also higher in diaphragm strips from BSO-treated animals compared with CTL; however, the difference between BSO and CTL was not significant (P ϭ 0.11) (Fig. 3B) .
Effects of BSO treatment on diaphragm fatigability. Diaphragm susceptibility to fatigue was assessed by repetitive stimulation of the muscle strips using the protocol outlined in MATERIALS AND METHODS. Compared with CTL, it took ϳ16 fewer contractions to induce a 50% loss in maximum tetanic force, and the overall reduction in force by the end of the fatigue protocol was greater (P Ͻ 0.05) in diaphragm strips from BSO-treated animals ( Table 1) .
SERCA function. The effects of BSO treatment and fatiguing contractile activity on SERCA function are illustrated in Fig. 4 . Compared with CTL, BSO treatment resulted in an increase in maximal Ca 2ϩ -ATPase activity of ϳ28% (Fig. 4A, open bars) and an increase in Ca 2ϩ uptake of ϳ25% (Fig. 4B , open bars) in diaphragm muscle under basal conditions (i.e., rest). Following fatiguing stimulation, both maximal Ca 2ϩ -ATPase activity and Ca 2ϩ uptake were increased (P Ͻ 0.05) in CTL diaphragm by ϳ31% and ϳ21%, respectively, whereas in BSO-treated animals, maximal Ca 2ϩ -ATPase activity and Ca 2ϩ uptake in diaphragm were not different (P Ͼ 0. (Fig. 5A) and SERCA2a (Fig. 5B) were compared between diaphragm muscles from BSO-treated animals and controls. No differences (P Ͼ 0.05) in SERCA1a expression levels were noted between CTL and BSO-treated animals, whereas SERCA2a content was increased ϳ2.2 fold in diaphragm muscle from BSO-treated animals compared with CTL (Fig. 5C ).
DISCUSSION
To assess the effects of a reduced antioxidant capacity and a more oxidized cellular redox state on diaphragm contractility and SERCA function, we treated rats with BSO to deplete cellular GSH and reduce the GSH/GSSG ratio, both of which did occur in this study, confirming treatment efficacy. Our results are in agreement with previous findings (26) that BSO treatment increases basal peak isometric force and increases diaphragm fatigability. We also show several novel effects of BSO treatment on SERCA protein expression and function. First, we measured SR Ca 2ϩ uptake and maximal SERCA activity in homogenates prepared from diaphragm under basal conditions, and both were increased with BSO treatment. Second, SERCA2a protein expression in diaphragm was increased with BSO treatment, suggesting that the expression of SERCA2a can be regulated by redox signaling. Finally, intense contractile activity results in an increased Ca 2ϩ uptake and maximal SERCA activity in diaphragm strips from control animals but not from BSO animals.
It is difficult to quantify changes in intracellular redox state without measuring changes in ROS or RNS concentrations. We did not measure ROS or RNS in diaphragm tissue, but we have reported previously that liver homogenate H 2 O 2 levels were increased by 42% in the BSO-treated rats that were used for this study (10) . That the GSH/GSSG ratio was not altered in liver but was reduced in diaphragm in BSO-treated animals would suggest that ROS and/or RNS levels may have been even higher in diaphragm under basal conditions. Nevertheless, the fact that diaphragm Hsp70 expression was not different between CTL and BSO suggests that the increased ROS and/or RNS concentrations that may have accumulated in the diaphragm from BSO animals were below the threshold required to induce a stress response. In contrast to our findings, Hsp70 levels were increased by ϳ63% in mouse soleus 24 h after a single 4 mmol/kg dose of BSO injected intraperitoneally (22) . BSO treatment, species, and/or muscle fiber type differences may explain the different Hsp70 responses between the studies. Fig. 3 . Basal isometric twitch and tetanic force of diaphragm strips from CTL rats and BSO-treated rats. Diaphragm muscle strips were prepared from CTL and BSO-treated animals, and basal peak isometric force amplitude was determined during a twitch and a maximal tetanic contraction (100 Hz) as described in MATERIALS AND METHODS. Force data were normalized for total muscle cross-sectional area (g/mm 2 ). A: peak twitch force. B: peak tetanic force measured at 100 Hz. Values are means Ϯ SE; n ϭ 10/group. *Significantly different from CTL (P Ͻ 0.05). Values are means Ϯ SE; n ϭ 10/group. BSO, buthionine sulfoximine. 50% Rundown is defined as the number of contractions needed to induce a 50% loss in tetanic force. *Significantly different from control (CTL). (P Ͻ 0.05). Fig. 4 . Effects of BSO treatment and fatigue on sarcoplasmic reticulum Ca 2ϩ -ATPase function. Ca 2ϩ -ATPase function was assessed in crude homogenates that were prepared from diaphragm strips from both CTL and BSOtreated animals either at rest (open bars) or following a fatiguing stimulation protocol (filled bars). See MATERIALS AND METHODS for details about the fatigue protocol. A: maximal Ca 2ϩ -ATPase activity, which occurred at pCa 5.6 -5.2, was measured using a spectrophotometric assay as described in MATERIALS AND METHODS. B: oxalate-supported Ca 2ϩ uptake was measured at pCa 5.82 using indo-1 as described in MATERIALS AND METHODS. Values are means Ϯ SE; n ϭ 8/group. *Significantly different from Rest (P Ͻ 0.05). #Significantly different from CTL (P Ͻ 0.05).
It is well known that oxidation of muscle under basal conditions within a narrow regulatory range augments isometric force but that this effect is reversed and force begins to decrease in a time-and dose-dependent manner with progressively higher levels of oxidation (33) . We found that peak twitch force was higher in diaphragm strips from BSO-treated animals compared with controls, which is consistent with the view that BSO treatment shifted cellular redox in diaphragm to a more optimal state for muscle contraction relative to CTL. Myofibrillar Ca 2ϩ sensitivity is reported to be the primary target for redox modulation of muscle contractility in the range where redox signaling causes an increase in muscle force (2, 3, 18, 29) . Interestingly, some studies have shown that application of low peroxide concentrations also increases maximum force in mammalian skeletal muscle, indicating that redox signaling may modulate cross-bridge function (3, 28) . Thus our observation that maximal tetanic force tended to be higher in diaphragm strips from BSO-treated animals compared with CTL may be attributable to redox modulation of cross-bridge function.
In theory, it is also possible that redox regulation of muscle contractility could be mediated through effects on Ca 2ϩ regulation by the SR since both the SR Ca 2ϩ release channel and SERCAs are responsive to changes in redox (1, 7, 20, 36) . For example, ROS-induced activation of the SR Ca 2ϩ release channel and/or inhibition of SERCAs would in both cases increase cytoplasmic [Ca 2ϩ ] and thus increase activation of the contractile apparatus. However, measurements of cytoplasmic [Ca 2ϩ ] in intact mouse fibers that were exposed to low peroxide concentrations indicate that cytoplasmic [Ca 2ϩ ] is actually reduced while submaximal force is increased (3). Therefore, oxidation-induced increases in muscle force are indeed independent of changes in SR function, yet these results and the results from our study indicate clearly that SR function is under the influence of redox regulation.
Unexpectedly, in this study we found that both Ca 2ϩ uptake and maximal SERCA activity measured in diaphragm homogenates under basal conditions were higher following BSO treatment. The increase in SERCA activity from BSO-treated diaphragms corresponded with a doubling of SERCA2a protein expression with no change in SERCA1a expression relative to controls. SERCA1a and SERCA2a are the major SERCA isoforms expressed in rat diaphragm, and reports of the relative proportion of SERCA2a in rat diaphragm range from ϳ10% (52) to ϳ43% (11) . Therefore, it is uncertain if the observed ϳ25% increase in both SERCA activity and Ca 2ϩ uptake can be accounted for entirely by the twofold increase in SERCA2a protein expression with BSO or if other mechanisms could also be involved.
Unlike our results on the effects of BSO on diaphragm contractility and SERCA function obtained under basal conditions where it appears that the shift in cellular redox to a more oxidized state underlies the differences between CTL and BSO, the different responses to fatiguing stimulation most likely reflects differences in antioxidant capacity and the degree of cellular oxidative stress between CTL and BSO that exists throughout the fatigue protocol. There is clear evidence that production of ROS in diaphragm increases with repeated contractions and that ROS induce diaphragmatic fatigue even in the presence of normal cellular antioxidant stores (31) . As expected, diaphragm fatigability was increased with BSO, which suggests that stimulation-induced oxidative stress was amplified with BSO because of lower cellular antioxidant buffering capacity in glutathione-depleted diaphragm. This interpretation is also consistent with the model developed by Reid et al. (32) that we referred to earlier, on the effects of cellular redox state on isometric force.
One of the major findings of this study was that the stimulation-induced increase in both SERCA activity and Ca 2ϩ uptake that was observed in CTL diaphragm strips was completely blunted in BSO-treated animals. Since diaphragm ROS levels increase with repeated contractions (31) and since it is well established that ROS can inhibit SERCA activity (8, 14, 53) , the fact that both SERCA activity and Ca 2ϩ uptake were increased following fatiguing stimulation in controls suggests that other signaling pathways that are activated with muscle contraction cause SERCA activity to increase, thus masking the negative effects of oxidative stress. If this interpretation is Fig. 5 . Western blot analysis of SERCA1a and SERCA2a from CTL and BSO-treated animals. Tissue homogenates were prepared from diaphragm samples taken before fatiguing stimulation from 6 CTL and 6 BSO-treated animals for measurement of both sarco(endo)plasmic reticulum Ca 2ϩ -ATPase (SERCA) 1a and SERCA2a protein levels by Western blot analysis. Homogenates were separated by SDS-PAGE on 7% acrylamide gels, transferred to PVDF membrane, and stained (1 h) with antibody A52 against SERCA1a (A) and antibody 2A7-A1 against SERCA2a (B). Staining with antibody 5C5 (Sigma) against ␣-actin was used as a control for protein loading (data not shown). Left lane: 10 l of biotinylated protein ladder was used as a molecular weight standard and was stained with horseradish peroxidase-conjugated anti-goat antibody against biotin. C: mean data for CTL and BSO normalized relative levels of SERCA1a (open bars) and SERCA2a (filled bars). Values are means Ϯ SE; n ϭ 6/group. Each sample was run in duplicate immunoblots. *Significantly different from CTL (P Ͻ 0.05).
correct, then a simple explanation for the results obtained from BSO animals is that contraction-induced oxidative stress would be higher in glutathione-depleted BSO diaphragm compared with controls and would completely offset any positive regulatory signals associated with muscle contraction, resulting in no change in either Ca 2ϩ uptake or SERCA activity in response to fatiguing stimulation.
Our study is not the first to report an increase in Ca 2ϩ uptake or maximal SERCA activity in response to repetitive muscle contractions. For example, both Ca 2ϩ uptake and maximal Ca 2ϩ -ATPase activity measured in rat hindlimb muscle are increased during recovery following a single bout of prolonged treadmill exercise (9, 38) . In another study, Holloway et al. (13) found that fatiguing stimulation of rat hindlimb muscle caused an increase in both Ca 2ϩ uptake and maximal SERCA activity in white gastrocnemius muscle, whereas, in contrast, both Ca 2ϩ uptake and maximal Ca 2ϩ -ATPase activity were reduced in red gastrocnemius and soleus. The different musclespecific responses are related to the oxidative potential of the muscle (13) and may reflect differences in second messenger regulation of SERCAs and/or redox homeostasis. Similarly, in response to different types of exercise, SR Ca 2ϩ uptake measured in rat diaphragm homogenates is either increased (43) or decreased (23) , which may reflect differences in ROS production and/or second messenger activation, depending on the exercise protocol employed.
In summary, we have found that BSO treatment in rats for 10 days depletes cellular GSH and reduces the GSH/GSSG ratio in diaphragm. BSO treatment increased diaphragm basal peak twitch force and increased diaphragm fatigability. SERCA activity, assessed in homogenates prepared from diaphragm under basal conditions, was upregulated with BSO treatment, which corresponded with an increase in SERCA2a protein expression. Fatiguing stimulation resulted in an increased Ca 2ϩ uptake and maximal SERCA activity in controls but not in BSO animals suggesting that regulation of SERCA activity in diaphragm likely involves a complex interaction between redox signaling and other signaling pathways that are activated with muscle contraction. This study contributes to a growing body of work supporting the view that free radicals play important biological roles in skeletal muscle (34) .
